US
“We have more than enough Pfizer and Moderna vaccines to cover all of the remaining eight and a half million people,”
First volunteers in early-stage trial were given their first injections on Wednesday, says Pfizer spokesperson
Drugmaker says the antiviral candidate showed potent activity against SARS-CoV-2 in lab studies
Ultra-cold freezers have capacity to maintain temperature at -70° C
India's drug regulator says its experts did not recommend vaccine because of side effects reported abroad
Initial data on immune responses expected to be generated around June
Pfizer says it can produce up to 1.3 billion doses around the world this year
Doctors are still studying whether doctor’s seizures and decreased muscle strength are related to Covid-19 vaccine
Trial participants who received the placebo will have two doses of the investigational vaccine reserved for them
UN health agency says it will work with regional partners to tell national health authorities about two-dose shot